Health Industry Washington Watch » Department of Health & Human Services Regulations

In a final rule published on April 26, the U.S. Department of Health and Human Services (“HHS”) amends the HIPAA Privacy Rule to bolster protections for individuals’ reproductive health inf...

https://www.healthindustrywashingtonwatch.com/2024/04/articles/regulatory-developments/hhs-developments/office-for-civil-rights-hhs-developments/hhs-modifies-hipaa-privacy-rule-to-shield-reproductive-health-information-from-third-party-access/

The Department of Health and Human Services (HHS) released a final rule today governing federal protections for health care workers exercising their right to nondiscrimination on the basis of con...

https://www.healthindustrywashingtonwatch.com/2024/01/articles/regulatory-developments/hhs-developments/office-for-civil-rights-hhs-developments/hhs-repeals-most-of-2019-health-care-conscience-protection-rule/

Three years after the Department of Health and Human Services’ (HHS) Office of the National Coordinator of Health Information Technology (ONC) issued a final rule that defined and clarified th...

https://www.healthindustrywashingtonwatch.com/2023/07/articles/regulatory-developments/hhs-developments/oig-finalizes-information-blocking-penalties/

The Department of Health and Human Services recently issued a proposed rule that would streamline the federal regulations governing the confidentiality of substance use disorder (SUD) patient rec...

https://www.healthindustrywashingtonwatch.com/2023/01/articles/department-of-health-and-human-services/hhs-updates-part-2-confidentiality-regulations-to-align-with-hipaa/

On June 29, 2022, the U.S. Department of Health & Human Services’ Office for Civil Rights (“OCR”) issued two pieces of guidance clarifying the applicability of the Health Insurance Portabil...

https://www.healthindustrywashingtonwatch.com/2022/07/articles/department-of-health-and-human-services/new-guidance-by-ocr-addresses-hipaa-and-disclosures-of-information-relating-to-reproductive-health/

In November 2020, four months after the Trump Administration issued a series of Executive Orders reiterating its policy goals on reducing the costs to consumers for prescription drugs and directi...

https://www.healthindustrywashingtonwatch.com/2021/12/articles/regulatory-developments/hhs-developments/future-of-discount-safe-harbor-for-prescription-drugs-remains-uncertain/

Effective January 1, 2022, common prohibitions against “balance billing” under hospital professional service contracts will likely become moot due to certain superseding federal prohibitions ...

https://www.healthindustrywashingtonwatch.com/2021/09/articles/regulatory-developments/hhs-developments/no-surprises-act-time-to-revisit-balance-billing-prohibitions-in-hospital-based-physician-professional-services-agreements-with-hospitals/

Over the last decade, members of the medical and public health communities around the world have widely studied and acknowledged the impact of social determinants of health (SDOH)—the condition...

https://www.healthindustrywashingtonwatch.com/2021/07/articles/regulatory-developments/hhs-developments/titleconsensus-among-hhs-agencies-on-addressing-social-determinants-of-health-through-better-data-capture-interoperability/

In 2010, the Affordable Care Act (ACA) directed the Secretary of Health and Human Services to issue regulations to establish an administrative dispute resolution (ADR) process for certain claims ...

https://www.healthindustrywashingtonwatch.com/2020/12/articles/department-of-health-and-human-services/long-awaited-issuance-of-section-340b-adr-final-rule/

Even amidst the chaos of a global pandemic, this year multiple U.S. Department of Health and Human Services (HHS) agencies have dialed in on promoting and enforcing patients’ rights to access t...

https://www.healthindustrywashingtonwatch.com/2020/10/articles/department-of-health-and-human-services/patient-access-to-health-information-at-the-forefront-of-government-initiatives-and-scrutiny/